Matthias Drosten

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 10

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Molecular oncology

PLoS genetics

Cell cycle (Georgetown, Tex.)

Centro Nacional de Investigaciones Oncológicas

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centro Nacional de Investigaciones Oncológicas

Spain

Investigator :: Molecular Oncology

Publications

Irati Macaya, Marta Roman, Connor Welch, Rodrigo Entrialgo-Cadierno, Marina Salmon, Alba Santos, Iker Feliu, Joanna R Kovalski, Ines Lopez, Maria Rodriguez-Remirez, Sara Palomino-Echeverria, Shane M Lonfgren, Macarena Ferrero, Silvia Calabuig, Iziar A Ludwig, David Lara-Astiaso, Eloísa Jantus-Lewintre, Elisabeth Guruceaga, Shruthi Narayanan, Mariano Ponz-Sarvisé, Antonio Pineda-Lucena, Fernando Lecanda, Davide Ruggero, Purvesh Khatri, Enrique Santamaria, Joaquin Fernandez-Irigoyen, Irene Ferrer, Luis Paz-Ares, Matthias Drosten, Mariano Barbacid, Ignacio Gil-Bazo, Silvestre Vincent
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer. Nature communications 14 (1) (2023)
Matthias Drosten, Mariano Barbacid
Targeting KRAS mutant lung cancer: light at the end of the tunnel. Molecular oncology 16 (5) (2022)
Matthias Drosten, Mariano Barbacid
KRAS inhibitors: going noncovalent. Molecular oncology 16 (22) (2022)
Guillem Paniagua, Harrys K C Jacob, Oksana Brehey, Sara García-Alonso, Carmen G Lechuga, Tirso Pons, Monica Musteanu, Carmen Guerra, Matthias Drosten, Mariano Barbacid
KSR induces RAS-independent MAPK pathway activation and modulates the efficacy of KRAS inhibitors. Molecular oncology 16 (17) (2022)
Marina Salmón, Guillem Paniagua, Carmen G Lechuga, Fernando Fernández-García, Eduardo Zarzuela, Ruth Álvarez-Díaz, Monica Musteanu, Carmen Guerra, Eduardo Caleiras, Javier Munoz, Sagrario Ortega, Matthias Drosten, Mariano Barbacid
KRAS4A induces metastatic lung adenocarcinomas in vivo in the absence of the KRAS4B isoform. Proceedings of the National Academy of Sciences of the United States of America 118 (30) (2021)
Jessica Vitos-Faleato, Sebastián M Real, Nuria Gutierrez-Prat, Alberto Villanueva, Elisabet Llonch, Matthias Drosten, Mariano Barbacid, Angel R Nebreda
Requirement for epithelial p38α in KRAS-driven lung tumor progression. Proceedings of the National Academy of Sciences of the United States of America 117 (5) (2020)
Laura Esteban-Burgos, Haiyun Wang, Patricia Nieto, Jie Zheng, Carmen Blanco-Aparicio, Carmen Varela, Gonzalo Gómez-López, Fernando Fernández-García, Manuel Sanclemente, Carmen Guerra, Matthias Drosten, Javier Galán, Eduardo Caleiras, Jorge L Martínez-Torrecuadrada, Lluis Fajas, Sheng-Bin Peng, David Santamaría, Monica Musteanu, Mariano Barbacid
Tumor regression and resistance mechanisms upon CDK4 and RAF1 inactivation in KRAS/P53 mutant lung adenocarcinomas. Proceedings of the National Academy of Sciences of the United States of America 117 (39) (2020)
Lucía Simón-Carrasco, Gerardo Jiménez, Mariano Barbacid, Matthias Drosten
The Capicua tumor suppressor: a gatekeeper of Ras signaling in development and cancer. Cell cycle (Georgetown, Tex.) 17 (6) (2019)
Marta Forés, Lucía Simón-Carrasco, Leiore Ajuria, Núria Samper, Sergio González-Crespo, Matthias Drosten, Mariano Barbacid, Gerardo Jiménez
A new mode of DNA binding distinguishes Capicua from other HMG-box factors and explains its mutation patterns in cancer. PLoS genetics 13 (3) (2017)
Lucía Simón-Carrasco, Osvaldo Graña, Marina Salmón, Harrys K C Jacob, Alejandro Gutierrez, Gerardo Jiménez, Matthias Drosten, Mariano Barbacid
Inactivation of Capicua in adult mice causes T-cell lymphoblastic lymphoma. Genes & development 31 (14) (2017)

Matthias Drosten.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Matthias Drosten